Загрузка...
Risdiplam distributes and increases SMN protein in both the central nervous system and peripheral organs
Spinal muscular atrophy (SMA) is a rare, inherited neuromuscular disease caused by deletion and/or mutation of the Survival of Motor Neuron 1 (SMN1) gene. A second gene, SMN2, produces low levels of functional SMN protein that are insufficient to fully compensate for the lack of SMN1. Risdiplam (RG7...
Сохранить в:
| Опубликовано в: : | Pharmacol Res Perspect |
|---|---|
| Главные авторы: | , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6262736/ https://ncbi.nlm.nih.gov/pubmed/30519476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.447 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|